FindTrial
Sign In

Predictive Value of Serum MST1 Protein Level for Postherpetic Neuralgia in the Elderly

Predictive Value of Serum MST1 Protein Level for Postherpetic Neuralgia in the Elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120424
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-23
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

PHN group and non-PHN group:No Intervention

Sponsors

The Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 65 years; 2.Clinically diagnosed with herpes zoster (typical clustered vesicles with pain, disease duration <= 7 days); 3.Conscious and able to cooperate with pain assessment and blood sample collection; 4.Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.Severe liver or kidney dysfunction, autoimmune diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus), or malignant tumors; 2.Severe cognitive impairment or mental illness that prevents follow-up or pain assessment; 3.History of neuropathic pain (e.g., diabetic peripheral neuropathy, trigeminal neuralgia); 4.Contraindications to blood sample collection (e.g., coagulation disorders).

Design outcomes

Primary

MeasureTime frame
Serum MST1 Protein Level;—

Countries

China

Contacts

Public ContactRen Yimin

The Affiliated Hospital of Guizhou Medical University

Yimin-ren@qq.com+86 139 8514 8563

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026